Literature DB >> 28177534

Laboratory diagnosis of Clostridium difficile infection: Comparison of Techlab C. diff Quik Chek Complete, Xpert C. difficile, and multistep algorithmic approach.

Ja Young Seo1, Ji Hun Jeong1, Kyung Hee Kim1, Jeong-Yeal Ahn1, Pil-Whan Park1, Yiel-Hea Seo1.   

Abstract

BACKGROUND: Clostridium difficile is a major pathogen responsible for nosocomial infectious diarrhea. We explored optimal laboratory strategies for diagnosis of C. difficile infection (CDI) in our clinical settings, a 1400-bed tertiary care hospital.
METHODS: Using 191 fresh stool samples from adult patients, we evaluated the performance of Xpert C. difficile (Xpert CD), C. diff Quik Chek Complete (which simultaneously detects glutamate dehydrogenase [GDH] and C. difficile toxins [CDT]), toxigenic culture, and a two-step algorithm composed of GDH/CDT as a screening test and Xpert CD as a confirmatory test.
RESULTS: Clostridium difficile was detected in 35 samples (18.3%), and all isolates were toxigenic strains. The sensitivity, specificity, positive predictive value (PPV), and negative predictive value of each assay for detecting CDI were as follows: Quik Chek Complete CDT (45.7%, 100%, 100%, 89.1%), Quik Chek Complete GDH (97.1%, 99.4%, 97.1%, 99.4%), Xpert CD (94.3%, 100%, 100%, 98.7%), and toxigenic culture (91.4%, 100%, 100%, 98.1%). A two-step algorithm performed identically with Xpert CD assay.
CONCLUSION: Our data showed that most C. difficile isolates from adult patients were toxigenic. We demonstrated that a two-step algorithm based on GDH/CDT assay followed by Xpert CD assay as a confirmatory test was rapid, reliable, and cost effective for diagnosis of CDI in an adult patient setting with high prevalence of toxigenic C. difficile.
© 2017 Wiley Periodicals, Inc.

Entities:  

Keywords:  zzm321990Clostridium difficilezzm321990; adult; diagnosis; glutamate dehydrogenase; multistep algorithm; tertiary care hospital

Mesh:

Year:  2017        PMID: 28177534      PMCID: PMC6817171          DOI: 10.1002/jcla.22135

Source DB:  PubMed          Journal:  J Clin Lab Anal        ISSN: 0887-8013            Impact factor:   2.352


  33 in total

1.  Evaluation of biosite triage Clostridium difficile panel for rapid detection of Clostridium difficile in stool samples.

Authors:  M L Landry; J Topal; D Ferguson; D Giudetti; Y Tang
Journal:  J Clin Microbiol       Date:  2001-05       Impact factor: 5.948

Review 2.  Diagnosis of Clostridium difficile infection by toxin detection kits: a systematic review.

Authors:  Tim Planche; Adamma Aghaizu; Richard Holliman; Peter Riley; Jan Poloniecki; Aodhán Breathnach; Sanjeev Krishna
Journal:  Lancet Infect Dis       Date:  2008-11-01       Impact factor: 25.071

3.  C. Diff Quik Chek complete enzyme immunoassay provides a reliable first-line method for detection of Clostridium difficile in stool specimens.

Authors:  Criziel D Quinn; Susan E Sefers; Wisal Babiker; Ying He; Romina Alcabasa; Charles W Stratton; Karen C Carroll; Yi-Wei Tang
Journal:  J Clin Microbiol       Date:  2009-12-02       Impact factor: 5.948

4.  Clostridium difficile infection diagnosis in a paediatric population: comparison of methodologies.

Authors:  J Hart; P Putsathit; D R Knight; L Sammels; T V Riley; A Keil
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2014-04-30       Impact factor: 3.267

5.  Evolution of testing algorithms at a university hospital for detection of Clostridium difficile infections.

Authors:  Karissa Culbreath; Edward Ager; Ronald J Nemeyer; Alan Kerr; Peter H Gilligan
Journal:  J Clin Microbiol       Date:  2012-06-20       Impact factor: 5.948

6.  The role of toxin A and toxin B in Clostridium difficile infection.

Authors:  Sarah A Kuehne; Stephen T Cartman; John T Heap; Michelle L Kelly; Alan Cockayne; Nigel P Minton
Journal:  Nature       Date:  2010-09-15       Impact factor: 49.962

7.  Clostridium difficile testing algorithms using glutamate dehydrogenase antigen and C. difficile toxin enzyme immunoassays with C. difficile nucleic acid amplification testing increase diagnostic yield in a tertiary pediatric population.

Authors:  Kaede V Ota; Karin L McGowan
Journal:  J Clin Microbiol       Date:  2012-01-18       Impact factor: 5.948

8.  Evaluation of tcdB real-time PCR in a three-step diagnostic algorithm for detection of toxigenic Clostridium difficile.

Authors:  Ann M Larson; Angela M Fung; Ferric C Fang
Journal:  J Clin Microbiol       Date:  2009-11-18       Impact factor: 5.948

9.  Performance of the TechLab C. DIFF CHEK-60 enzyme immunoassay (EIA) in combination with the C. difficile Tox A/B II EIA kit, the Triage C. difficile panel immunoassay, and a cytotoxin assay for diagnosis of Clostridium difficile-associated diarrhea.

Authors:  Heather Snell; Meredith Ramos; Sue Longo; Michael John; Zafar Hussain
Journal:  J Clin Microbiol       Date:  2004-10       Impact factor: 5.948

10.  Performance of chromID Clostridium difficile agar compared with BBL C. difficile selective agar for detection of C. difficile in stool specimens.

Authors:  Sang Bong Han; Jiyoung Chang; Sang Hyun Shin; Kang Gyun Park; Gun Dong Lee; Yong Gyu Park; Yeon-Joon Park
Journal:  Ann Lab Med       Date:  2014-08-21       Impact factor: 3.464

View more
  5 in total

1.  Evaluation of glutamate dehydrogenase (GDH) and toxin A/B rapid tests for Clostridioides (prev. Clostridium) difficile diagnosis in a university hospital in Minas Gerais, Brazil.

Authors:  Carolina Pantuzza Ramos; Emily Oliveira Lopes; Amanda Nádia Diniz; Francisco Carlos Faria Lobato; Eduardo Garcia Vilela; Rodrigo Otávio Silveira Silva
Journal:  Braz J Microbiol       Date:  2020-05-04       Impact factor: 2.476

2.  Rapid Quantification of C. difficile Glutamate Dehydrogenase and Toxin B (TcdB) with a NanoBiT Split-Luciferase Assay.

Authors:  Hope Adamson; Modupe O Ajayi; Kate E Gilroy; Michael J McPherson; Darren C Tomlinson; Lars J C Jeuken
Journal:  Anal Chem       Date:  2022-05-28       Impact factor: 8.008

3.  Laboratory Diagnostic Methods for Clostridioides difficile Infection: the First Systematic Review and Meta-analysis in Korea.

Authors:  Hae-Sun Chung; Jeong Su Park; Bo-Moon Shin
Journal:  Ann Lab Med       Date:  2021-03-01       Impact factor: 3.464

4.  Comparison of commercial assays and two-step approach to detect Clostridioides difficile in South Africa.

Authors:  Sarishna Singh; Mae Newton-Foot; Pieter Nel; Colette Pienaar
Journal:  Afr J Lab Med       Date:  2022-09-29

5.  Performance comparison of the cobas Liat and Cepheid GeneXpert systems for Clostridium difficile detection.

Authors:  Paul A Granato; Glen Hansen; Emily Herding; Sheena Chaudhuri; Shaowu Tang; Sachin K Garg; Catherine R Rowell; Joanna Jackson Sickler
Journal:  PLoS One       Date:  2018-07-24       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.